RxDoctor Payments Data

Audra Mihalic

Family · Lorain, OHNPI 1235618372

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $871 and has fallen 82.6% since, to $151 in 2023.

$1,710in general payments, 2019–2025

Across 106 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$243
  • AstraZeneca$220
  • AbbVie$219
  • Novo Nordisk$213
  • Otsuka America Pharmaceutical, Inc.$112
  • Lilly USA, LLC$95
  • plus $607 from 15 others

What the payments were for

  • Food & beverage$1,710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,710 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Other family in Lorain

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →